Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices ...
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback